Morinaga gets FDA GRAS approval fpr new probiotic
date:Nov 08, 2013
d probiotic strains in the world. Thirty-four scientific papers on M-16V are said to have been published that support the use of this probiotic in maintaining health in humans.

M-16V has been recognized for its safety and effectiveness, especially for low-birth-weight infants to help promote healthy growth, and is used in approximately 100 hospitals in Japan for low-birth-weight infants in Neonatal Intensive Care Units (NICU). Because of its effectiveness, some doctors cannot stop using it in t
5/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/31 23:18